BioStock publishes updated analysis of Idogen
BioStock has yesterday, the 12th of September 2017, published an updated analysis of Idogen. The analysis is now available on BioStock’s and Idogen’s websites (www.biostock.se , www.idogen.com ). On behalf of Idogen, Biostock has analyzed the company’s project portfolio and will continue to follow the company.Extract from BioStock’s analysis: “Idogens present market cap or around SEK 100 million can be viewed as conservative, given that the company has received 42.5 million SEK in